ID   SIN3A_HUMAN             Reviewed;        1273 AA.
AC   Q96ST3; B2RNS5; Q8N8N4; Q8NC83; Q8WV18; Q96L98; Q9UFQ1;
DT   24-OCT-2003, integrated into UniProtKB/Swiss-Prot.
DT   24-OCT-2003, sequence version 2.
DT   10-MAY-2017, entry version 159.
DE   RecName: Full=Paired amphipathic helix protein Sin3a;
DE   AltName: Full=Histone deacetylase complex subunit Sin3a;
DE   AltName: Full=Transcriptional corepressor Sin3a;
GN   Name=SIN3A {ECO:0000312|HGNC:HGNC:19353};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:AAP97288.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Guo J.H., Yu L.;
RL   Submitted (SEP-2001) to the EMBL/GenBank/DDBJ databases.
RN   [2] {ECO:0000305, ECO:0000312|EMBL:AAH18973.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung, and Uterus {ECO:0000312|EMBL:AAH18973.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-1026.
RC   TISSUE=Brain, and Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4] {ECO:0000305, ECO:0000312|EMBL:AAP97288.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-620.
RA   Bu X., Fu Y., Jiang S., Avraham S., Avraham H.;
RL   Submitted (JUL-2001) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 913-1273.
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6] {ECO:0000305}
RP   INTERACTION WITH SFPQ.
RX   PubMed=11259580; DOI=10.1128/MCB.21.7.2298-2311.2001;
RA   Mathur M., Tucker P.W., Samuels H.H.;
RT   "PSF is a novel corepressor that mediates its effect through Sin3A and
RT   the DNA binding domain of nuclear hormone receptors.";
RL   Mol. Cell. Biol. 21:2298-2311(2001).
RN   [7]
RP   INTERACTION WITH OGT, AND FUNCTION.
RX   PubMed=12150998; DOI=10.1016/S0092-8674(02)00810-3;
RA   Yang X., Zhang F., Kudlow J.E.;
RT   "Recruitment of O-GlcNAc transferase to promoters by corepressor
RT   mSin3A: coupling protein O-GlcNAcylation to transcriptional
RT   repression.";
RL   Cell 110:69-80(2002).
RN   [8] {ECO:0000305}
RP   INTERACTION WITH SFPQ.
RX   PubMed=11897684; DOI=10.1210/endo.143.4.8748;
RA   Sewer M.B., Nguyen V.Q., Huang C.J., Tucker P.W., Kagawa N.,
RA   Waterman M.R.;
RT   "Transcriptional activation of human CYP17 in H295R adrenocortical
RT   cells depends on complex formation among p54(nrb)/NonO, protein-
RT   associated splicing factor, and SF-1, a complex that also participates
RT   in repression of transcription.";
RL   Endocrinology 143:1280-1290(2002).
RN   [9] {ECO:0000305}
RP   INTERACTION WITH DACH1.
RX   PubMed=14525983; DOI=10.1074/jbc.M310021200;
RA   Wu K., Yang Y., Wang C., Davoli M.A., D'Amico M., Li A., Cveklova K.,
RA   Kozmik Z., Lisanti M.P., Russell R.G., Cvekl A., Pestell R.G.;
RT   "DACH1 inhibits transforming growth factor-beta signaling through
RT   binding Smad4.";
RL   J. Biol. Chem. 278:51673-51684(2003).
RN   [10] {ECO:0000305}
RP   INTERACTION WITH HCFC1.
RX   PubMed=12670868; DOI=10.1101/gad.252103;
RA   Wysocka J., Myers M.P., Laherty C.D., Eisenman R.N., Herr W.;
RT   "Human Sin3 deacetylase and trithorax-related Set1/Ash2 histone H3-K4
RT   methyltransferase are tethered together selectively by the cell-
RT   proliferation factor HCF-1.";
RL   Genes Dev. 17:896-911(2003).
RN   [11]
RP   INTERACTION WITH SAP130; SUDS3; ARID4B; HDAC1 AND HDAC2.
RX   PubMed=12724404; DOI=10.1128/MCB.23.10.3456-3467.2003;
RA   Fleischer T.C., Yun U.J., Ayer D.E.;
RT   "Identification and characterization of three new components of the
RT   mSin3A corepressor complex.";
RL   Mol. Cell. Biol. 23:3456-3467(2003).
RN   [12]
RP   INTERACTION WITH BRMS1L.
RX   PubMed=15451426; DOI=10.1016/j.bbrc.2004.08.227;
RA   Nikolaev A.Y., Papanikolaou N.A., Li M., Qin J., Gu W.;
RT   "Identification of a novel BRMS1-homologue protein p40 as a component
RT   of the mSin3A/p33(ING1b)/HDAC1 deacetylase complex.";
RL   Biochem. Biophys. Res. Commun. 323:1216-1222(2004).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-860, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [14]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH SAP30L.
RX   PubMed=16820529; DOI=10.1093/nar/gkl401;
RA   Viiri K.M., Korkeamaeki H., Kukkonen M.K., Nieminen L.K., Lindfors K.,
RA   Peterson P., Maeki M., Kainulainen H., Lohi O.;
RT   "SAP30L interacts with members of the Sin3A corepressor complex and
RT   targets Sin3A to the nucleolus.";
RL   Nucleic Acids Res. 34:3288-3298(2006).
RN   [15]
RP   INTERACTION WITH PPHLN1.
RX   PubMed=17963697; DOI=10.1016/j.bbrc.2007.10.090;
RA   Kurita M., Suzuki H., Kawano Y., Aiso S., Matsuoka M.;
RT   "CR/periphilin is a transcriptional co-repressor involved in cell
RT   cycle progression.";
RL   Biochem. Biophys. Res. Commun. 364:930-936(2007).
RN   [16]
RP   INTERACTION WITH TOPORS, SUMOYLATION BY TOPORS, AND DESUMOYLATION BY
RP   SENP2.
RX   PubMed=17803295; DOI=10.1021/pr0703674;
RA   Pungaliya P., Kulkarni D., Park H.J., Marshall H., Zheng H.,
RA   Lackland H., Saleem A., Rubin E.H.;
RT   "TOPORS functions as a SUMO-1 E3 ligase for chromatin-modifying
RT   proteins.";
RL   J. Proteome Res. 6:3918-3923(2007).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-10, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-10; SER-277; SER-832;
RP   SER-940 AND SER-1112, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-832 AND SER-1112, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [20]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-469, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-832; SER-860; SER-940
RP   AND SER-1112, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [23]
RP   INTERACTION WITH TET1.
RX   PubMed=21490601; DOI=10.1038/nature10066;
RA   Williams K., Christensen J., Pedersen M.T., Johansen J.V., Cloos P.A.,
RA   Rappsilber J., Helin K.;
RT   "TET1 and hydroxymethylcytosine in transcription and DNA methylation
RT   fidelity.";
RL   Nature 473:343-348(2011).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-832 AND SER-860, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-10; SER-832; SER-940 AND
RP   SER-1112, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1089, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Acts as a transcriptional repressor. Corepressor for
CC       REST. Interacts with MXI1 to repress MYC responsive genes and
CC       antagonize MYC oncogenic activities. Also interacts with MXD1-MAX
CC       heterodimers to repress transcription by tethering SIN3A to DNA.
CC       Acts cooperatively with OGT to repress transcription in parallel
CC       with histone deacetylation. Involved in he control of the
CC       circadian rhythms. Required for the transcriptional repression of
CC       circadian target genes, such as PER1, mediated by the large PER
CC       complex through histone deacetylation. Cooperates with FOXK1 to
CC       regulate cell cycle progression probably by repressing cell cycle
CC       inhibitor genes expression (By similarity).
CC       {ECO:0000250|UniProtKB:Q60520, ECO:0000269|PubMed:12150998}.
CC   -!- SUBUNIT: Interacts with ARID4B, BRMS1L, HCFC1, HDAC1, HDAC2, MXI1,
CC       SAP30L, SAP130, SFPQ and TOPORS. Interacts with OGT (via TPRs 1-
CC       6); the interaction mediates transcriptional repression in
CC       parallel with histone deacetylase (By similarity). Interacts with
CC       BAZ2A, MXD3, MXD4, MBD2, DACH1, NCOR1, NR4A2, REST, RLIM, SAP30,
CC       SETDB1, SMYD2, and SUDS3. Interacts with PHF12 in a complex
CC       composed of HDAC1, PHF12 and SAP30. Interacts with TET1; the
CC       interaction recruits SIN3A to gene promoters. The large PER
CC       complex involved in the histone deacetylation is composed of at
CC       least HDAC1, PER2, SFPQ and SIN3A. Interacts with KLF11 (By
CC       similarity). Interacts with PPHLN1 (PubMed:17963697). Found in a
CC       complex with YY1, GON4L and HDAC1 (By similarity). Interacts (via
CC       PAH2) with FOXK1 (By similarity). {ECO:0000250|UniProtKB:Q60520,
CC       ECO:0000269|PubMed:11259580, ECO:0000269|PubMed:11897684,
CC       ECO:0000269|PubMed:12150998, ECO:0000269|PubMed:12670868,
CC       ECO:0000269|PubMed:12724404, ECO:0000269|PubMed:14525983,
CC       ECO:0000269|PubMed:15451426, ECO:0000269|PubMed:16820529,
CC       ECO:0000269|PubMed:17803295, ECO:0000269|PubMed:17963697,
CC       ECO:0000269|PubMed:21490601}.
CC   -!- INTERACTION:
CC       Q7L2E3:DHX30; NbExp=3; IntAct=EBI-347218, EBI-1211456;
CC       P51610:HCFC1; NbExp=6; IntAct=EBI-347218, EBI-396176;
CC       Q92769:HDAC2; NbExp=5; IntAct=EBI-347218, EBI-301821;
CC       Q9Y4K0:LOXL2; NbExp=2; IntAct=EBI-347218, EBI-7172227;
CC       Q9Y5X4:NR2E3; NbExp=2; IntAct=EBI-347218, EBI-7216962;
CC       Q9UQ80:PA2G4; NbExp=4; IntAct=EBI-347218, EBI-924893;
CC       Q16576:RBBP7; NbExp=2; IntAct=EBI-347218, EBI-352227;
CC       P23246:SFPQ; NbExp=2; IntAct=EBI-347218, EBI-355453;
CC       P12755:SKI; NbExp=3; IntAct=EBI-347218, EBI-347281;
CC       P04637:TP53; NbExp=2; IntAct=EBI-347218, EBI-366083;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00810, ECO:0000269|PubMed:16820529}. Nucleus, nucleolus
CC       {ECO:0000269|PubMed:16820529}. Note=Recruited to the nucleolus by
CC       SAP30L.
CC   -!- PTM: SUMO1 sumoylated by TOPORS. Probably desumoylated by SENP2.
CC       {ECO:0000269|PubMed:17803295}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF418569; AAP97288.1; -; mRNA.
DR   EMBL; BC018973; AAH18973.1; -; mRNA.
DR   EMBL; BC137098; AAI37099.1; -; mRNA.
DR   EMBL; BC137099; AAI37100.1; -; mRNA.
DR   EMBL; AK027559; BAB55197.1; -; mRNA.
DR   EMBL; AK074903; BAC11280.1; -; mRNA.
DR   EMBL; AK096477; BAC04801.1; -; mRNA.
DR   EMBL; AY044430; AAK95854.1; -; mRNA.
DR   EMBL; AL117513; CAB55972.1; -; mRNA.
DR   CCDS; CCDS10279.1; -.
DR   PIR; T17282; T17282.
DR   RefSeq; NP_001138829.1; NM_001145357.1.
DR   RefSeq; NP_001138830.1; NM_001145358.1.
DR   RefSeq; NP_056292.1; NM_015477.2.
DR   RefSeq; XP_006720528.1; XM_006720465.3.
DR   RefSeq; XP_006720529.1; XM_006720466.3.
DR   RefSeq; XP_006720530.1; XM_006720467.3.
DR   UniGene; Hs.513039; -.
DR   PDB; 1PO4; Model; -; B=295-383.
DR   PDBsum; 1PO4; -.
DR   ProteinModelPortal; Q96ST3; -.
DR   SMR; Q96ST3; -.
DR   BioGrid; 117439; 207.
DR   DIP; DIP-31515N; -.
DR   IntAct; Q96ST3; 54.
DR   MINT; MINT-2815493; -.
DR   STRING; 9606.ENSP00000353622; -.
DR   iPTMnet; Q96ST3; -.
DR   PhosphoSitePlus; Q96ST3; -.
DR   BioMuta; SIN3A; -.
DR   DMDM; 37999759; -.
DR   EPD; Q96ST3; -.
DR   MaxQB; Q96ST3; -.
DR   PaxDb; Q96ST3; -.
DR   PeptideAtlas; Q96ST3; -.
DR   PRIDE; Q96ST3; -.
DR   Ensembl; ENST00000360439; ENSP00000353622; ENSG00000169375.
DR   Ensembl; ENST00000394947; ENSP00000378402; ENSG00000169375.
DR   Ensembl; ENST00000394949; ENSP00000378403; ENSG00000169375.
DR   GeneID; 25942; -.
DR   KEGG; hsa:25942; -.
DR   UCSC; uc002bai.4; human.
DR   CTD; 25942; -.
DR   DisGeNET; 25942; -.
DR   GeneCards; SIN3A; -.
DR   H-InvDB; HIX0012443; -.
DR   H-InvDB; HIX0019634; -.
DR   H-InvDB; HIX0172841; -.
DR   HGNC; HGNC:19353; SIN3A.
DR   HPA; CAB004506; -.
DR   HPA; HPA047213; -.
DR   HPA; HPA062123; -.
DR   MIM; 607776; gene.
DR   neXtProt; NX_Q96ST3; -.
DR   OpenTargets; ENSG00000169375; -.
DR   PharmGKB; PA134993567; -.
DR   eggNOG; KOG4204; Eukaryota.
DR   eggNOG; COG5602; LUCA.
DR   GeneTree; ENSGT00390000007239; -.
DR   HOVERGEN; HBG060425; -.
DR   InParanoid; Q96ST3; -.
DR   KO; K11644; -.
DR   OMA; EENCFKI; -.
DR   OrthoDB; EOG091G03HY; -.
DR   PhylomeDB; Q96ST3; -.
DR   TreeFam; TF106187; -.
DR   Reactome; R-HSA-400206; Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha).
DR   Reactome; R-HSA-427413; NoRC negatively regulates rRNA expression.
DR   Reactome; R-HSA-983231; Factors involved in megakaryocyte development and platelet production.
DR   SIGNOR; Q96ST3; -.
DR   ChiTaRS; SIN3A; human.
DR   GeneWiki; SIN3A; -.
DR   GenomeRNAi; 25942; -.
DR   PRO; PR:Q96ST3; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000169375; -.
DR   CleanEx; HS_SIN3A; -.
DR   ExpressionAtlas; Q96ST3; baseline and differential.
DR   Genevisible; Q96ST3; HS.
DR   GO; GO:0000776; C:kinetochore; IEA:Ensembl.
DR   GO; GO:0005730; C:nucleolus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:BHF-UCL.
DR   GO; GO:0016580; C:Sin3 complex; IDA:UniProtKB.
DR   GO; GO:0005667; C:transcription factor complex; IEA:Ensembl.
DR   GO; GO:0017053; C:transcriptional repressor complex; IEA:Ensembl.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0032403; F:protein complex binding; IEA:Ensembl.
DR   GO; GO:0033558; F:protein deacetylase activity; IMP:BHF-UCL.
DR   GO; GO:0003723; F:RNA binding; IEA:Ensembl.
DR   GO; GO:0001102; F:RNA polymerase II activating transcription factor binding; IPI:BHF-UCL.
DR   GO; GO:0001103; F:RNA polymerase II repressing transcription factor binding; IEA:Ensembl.
DR   GO; GO:0001106; F:RNA polymerase II transcription corepressor activity; IBA:GO_Central.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0000976; F:transcription regulatory region sequence-specific DNA binding; ISS:UniProtKB.
DR   GO; GO:0002218; P:activation of innate immune response; IMP:BHF-UCL.
DR   GO; GO:0007568; P:aging; IEA:Ensembl.
DR   GO; GO:0044255; P:cellular lipid metabolic process; TAS:Reactome.
DR   GO; GO:0034613; P:cellular protein localization; IEA:Ensembl.
DR   GO; GO:1903351; P:cellular response to dopamine; IEA:Ensembl.
DR   GO; GO:0071333; P:cellular response to glucose stimulus; IEA:Ensembl.
DR   GO; GO:0006260; P:DNA replication; IEA:Ensembl.
DR   GO; GO:0002244; P:hematopoietic progenitor cell differentiation; IEA:Ensembl.
DR   GO; GO:0016575; P:histone deacetylation; IBA:GO_Central.
DR   GO; GO:0001701; P:in utero embryonic development; IEA:Ensembl.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0042754; P:negative regulation of circadian rhythm; ISS:UniProtKB.
DR   GO; GO:1901675; P:negative regulation of histone H3-K27 acetylation; IMP:BHF-UCL.
DR   GO; GO:1900181; P:negative regulation of protein localization to nucleus; IMP:BHF-UCL.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL.
DR   GO; GO:2000678; P:negative regulation of transcription regulatory region DNA binding; IMP:BHF-UCL.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   GO; GO:0031937; P:positive regulation of chromatin silencing; IMP:BHF-UCL.
DR   GO; GO:0002230; P:positive regulation of defense response to virus by host; IMP:BHF-UCL.
DR   GO; GO:0010971; P:positive regulation of G2/M transition of mitotic cell cycle; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL.
DR   GO; GO:0006476; P:protein deacetylation; IMP:BHF-UCL.
DR   GO; GO:0010817; P:regulation of hormone levels; IEA:Ensembl.
DR   GO; GO:0043619; P:regulation of transcription from RNA polymerase II promoter in response to oxidative stress; IEA:Ensembl.
DR   GO; GO:0051595; P:response to methylglyoxal; IEA:Ensembl.
DR   GO; GO:0048511; P:rhythmic process; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   InterPro; IPR013194; HDAC_interact_dom.
DR   InterPro; IPR003822; PAH.
DR   InterPro; IPR031693; Sin3_C.
DR   Pfam; PF02671; PAH; 3.
DR   Pfam; PF08295; Sin3_corepress; 1.
DR   Pfam; PF16879; Sin3a_C; 1.
DR   SMART; SM00761; HDAC_interact; 1.
DR   SUPFAM; SSF47762; SSF47762; 3.
DR   PROSITE; PS51477; PAH; 3.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Biological rhythms; Coiled coil;
KW   Complete proteome; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat; Repressor; Transcription;
KW   Transcription regulation; Ubl conjugation.
FT   CHAIN         1   1273       Paired amphipathic helix protein Sin3a.
FT                                /FTId=PRO_0000121537.
FT   DOMAIN      119    189       PAH 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00810}.
FT   DOMAIN      300    383       PAH 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00810}.
FT   DOMAIN      456    525       PAH 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00810}.
FT   REGION      119    196       Interaction with HCFC1.
FT                                {ECO:0000269|PubMed:12670868}.
FT   REGION      205    480       Interaction with REST. {ECO:0000250}.
FT   REGION      458    525       Interaction with SAP30.
FT                                {ECO:0000250|UniProtKB:Q60520}.
FT   REGION      523    850       Interaction with NCOR1.
FT                                {ECO:0000250|UniProtKB:Q60520}.
FT   REGION      524    659       Interaction with SUDS3 and SAP130.
FT                                {ECO:0000269|PubMed:12724404}.
FT   REGION      687    829       Interaction with HDAC1 and ARID4B.
FT                                {ECO:0000269|PubMed:12724404}.
FT   REGION      888    967       Interaction with OGT.
FT                                {ECO:0000269|PubMed:12150998}.
FT   COILED      903    932       {ECO:0000255}.
FT   COMPBIAS    218    285       Pro-rich.
FT   COMPBIAS    835    841       Poly-Glu.
FT   MOD_RES      10     10       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     277    277       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     284    284       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q60520}.
FT   MOD_RES     469    469       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     832    832       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     860    860       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES     865    865       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q60520}.
FT   MOD_RES     875    875       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q60520}.
FT   MOD_RES     940    940       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1089   1089       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1112   1112       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   VARIANT    1156   1156       M -> L (in dbSNP:rs60213317).
FT                                /FTId=VAR_062129.
FT   CONFLICT    163    163       G -> R (in Ref. 4; AAK95854).
FT                                {ECO:0000305}.
FT   CONFLICT    170    177       QLFKGHPD -> HYSKGPPI (in Ref. 4;
FT                                AAK95854). {ECO:0000305}.
FT   CONFLICT    182    192       FNTFLPPGYKI -> IQHLFAPWATKM (in Ref. 4;
FT                                AAK95854). {ECO:0000305}.
FT   CONFLICT    216    216       I -> T (in Ref. 3; BAC04801).
FT                                {ECO:0000305}.
FT   CONFLICT    386    386       S -> F (in Ref. 4; AAK95854).
FT                                {ECO:0000305}.
FT   CONFLICT    536    536       E -> D (in Ref. 4; AAK95854).
FT                                {ECO:0000305}.
FT   CONFLICT    562    562       P -> G (in Ref. 4; AAK95854).
FT                                {ECO:0000305}.
FT   CONFLICT    575    576       PL -> GV (in Ref. 4; AAK95854).
FT                                {ECO:0000305}.
FT   CONFLICT    595    595       S -> C (in Ref. 4; AAK95854).
FT                                {ECO:0000305}.
FT   CONFLICT    618    620       ELD -> DLM (in Ref. 4; AAK95854).
FT                                {ECO:0000305}.
FT   CONFLICT   1009   1009       Q -> R (in Ref. 3; BAC11280).
FT                                {ECO:0000305}.
FT   CONFLICT   1247   1248       TT -> NN (in Ref. 1; AAP97288).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1273 AA;  145175 MW;  E6A329BE0EAD84CD CRC64;
     MKRRLDDQES PVYAAQQRRI PGSTEAFPHQ HRVLAPAPPV YEAVSETMQS ATGIQYSVTP
     SYQVSAMPQS SGSHGPAIAA VHSSHHHPTA VQPHGGQVVQ SHAHPAPPVA PVQGQQQFQR
     LKVEDALSYL DQVKLQFGSQ PQVYNDFLDI MKEFKSQSID TPGVISRVSQ LFKGHPDLIM
     GFNTFLPPGY KIEVQTNDMV NVTTPGQVHQ IPTHGIQPQP QPPPQHPSQP SAQSAPAPAQ
     PAPQPPPAKV SKPSQLQAHT PASQQTPPLP PYASPRSPPV QPHTPVTISL GTAPSLQNNQ
     PVEFNHAINY VNKIKNRFQG QPDIYKAFLE ILHTYQKEQR NAKEAGGNYT PALTEQEVYA
     QVARLFKNQE DLLSEFGQFL PDANSSVLLS KTTAEKVDSV RNDHGGTVKK PQLNNKPQRP
     SQNGCQIRRH PTGTTPPVKK KPKLLNLKDS SMADASKHGG GTESLFFDKV RKALRSAEAY
     ENFLRCLVIF NQEVISRAEL VQLVSPFLGK FPELFNWFKN FLGYKESVHL ETYPKERATE
     GIAMEIDYAS CKRLGSSYRA LPKSYQQPKC TGRTPLCKEV LNDTWVSFPS WSEDSTFVSS
     KKTQYEEHIY RCEDERFELD VVLETNLATI RVLEAIQKKL SRLSAEEQAK FRLDNTLGGT
     SEVIHRKALQ RIYADKAADI IDGLRKNPSI AVPIVLKRLK MKEEEWREAQ RGFNKVWREQ
     NEKYYLKSLD HQGINFKQND TKVLRSKSLL NEIESIYDER QEQATEENAG VPVGPHLSLA
     YEDKQILEDA AALIIHHVKR QTGIQKEDKY KIKQIMHHFI PDLLFAQRGD LSDVEEEEEE
     EMDVDEATGA VKKHNGVGGS PPKSKLLFSN TAAQKLRGMD EVYNLFYVNN NWYIFMRLHQ
     ILCLRLLRIC SQAERQIEEE NREREWEREV LGIKRDKSDS PAIQLRLKEP MDVDVEDYYP
     AFLDMVRSLL DGNIDSSQYE DSLREMFTIH AYIAFTMDKL IQSIVRQLQH IVSDEICVQV
     TDLYLAENNN GATGGQLNTQ NSRSLLESTY QRKAEQLMSD ENCFKLMFIQ SQGQVQLTIE
     LLDTEEENSD DPVEAERWSD YVERYMNSDT TSPELREHLA QKPVFLPRNL RRIRKCQRGR
     EQQEKEGKEG NSKKTMENVD SLDKLECRFK LNSYKMVYVI KSEDYMYRRT ALLRAHQSHE
     RVSKRLHQRF QAWVDKWTKE HVPREMAAET SKWLMGEGLE GLVPCTTTCD TETLHFVSIN
     KYRVKYGTVF KAP
//
